Disclosed positions

Estimated from their latest filings — positions may have changed since

$2.93M

combined est. value

Stock	Shares	Price	Value	Weight	As of
NEONEOGENOMICS INC	96,729	$15.16	$1.47M	50%	2026-06-01
RYTMRHYTHM PHARMACEUTICALS, INC.	11,712	$115.48	$1.35M	46%	2026-06-23
ALMSALUMIS INC.	3,553	$30.30	$107.7K	4%	2026-06-30

NEO

NEOGENOMICS INC

$1.47M

96,729 sh

RYTM

RHYTHM PHARMACEUTICALS, INC.

$1.35M

11,712 sh

ALMS

ALUMIS INC.

$107.7K

3,553 sh

All filings on record

Every Form 4 transaction we track for this filer

all 5buys 0sells 0

Stock	Transaction	Date	~6mo later
ALMSALUMIS INC.	Grant — · 3,553 sh	2026-06-30	—
RYTMRHYTHM PHARMACEUTICALS, INC.	Exercise — · 4,712 sh	2026-06-23	—
NEONEOGENOMICS INC	Exercise — · 23,077 sh	2026-06-01	—
RYTMRHYTHM PHARMACEUTICALS, INC.	Exercise — · 4,000 sh	2025-06-18	—
NEONEOGENOMICS INC	Exercise — · 12,254 sh	2025-06-01	—

ALMSGrant

2026-06-30 · ALUMIS INC.

3,553

—

RYTMExercise

2026-06-23 · RHYTHM PHARMACEUTICALS, INC.

4,712

—

NEOExercise

2026-06-01 · NEOGENOMICS INC

23,077

—

RYTMExercise

2025-06-18 · RHYTHM PHARMACEUTICALS, INC.

4,000

—

NEOExercise

2025-06-01 · NEOGENOMICS INC

12,254

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.